Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Multiple Allele Traits01:49

Multiple Allele Traits

38.5K
The Concept of Multiple Allelism
38.5K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

2.6K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.6K
Translation01:31

Translation

158.7K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
158.7K
Translation01:31

Translation

21.1K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
21.1K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.7K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Undetectable Hydroxyurea Levels in the Majority of Sickle Cell Disease Patients, Especially in Young Children.

American journal of hematology·2026
Same author

Exa-cel in Children with Transfusion-Dependent β-Thalassemia or Sickle Cell Disease.

The New England journal of medicine·2026
Same author

EHA Recommendations for preconceptual and antenatal screening and prenatal diagnosis for hemoglobinopathies.

HemaSphere·2026
Same author

Better 10-Year Cerebrovascular Outcome After Transplant Than on Standard-Care in Sickle Cell Anemia: DREPAGREFFE Trial.

American journal of hematology·2026
Same author

Cryopreservation of Red Blood Cells From Sickle Cell Disease Patients for Comparison of Oxygen Gradient Ektacytometry Parameters Between Laboratories to Enable Data Harmonization.

International journal of laboratory hematology·2026
Same author

African Representation in Randomized Controlled Trials Published in Leading Medical and Cardiovascular Journals, 2019-2024.

Journal of the American College of Cardiology·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Mar 8, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

2.0K

Enfermedad falciforme

Russell E Ware1, Mariane de Montalembert2, Léon Tshilolo3

  • 1Division of Hematology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Lancet (London, England)
|February 5, 2017
PubMed
Resumen
Este resumen es generado por máquina.

La anemia falciforme causa dolor intenso y daño a los órganos debido a que los glóbulos rojos anormales bloquean el flujo sanguíneo. Las nuevas terapias génicas ofrecen la esperanza de una cura, junto con mejores diagnósticos y estrategias de manejo.

Más Videos Relacionados

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
08:23

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

10.4K
Magnetic Levitation Coupled with Portable Imaging and Analysis for Disease Diagnostics
07:42

Magnetic Levitation Coupled with Portable Imaging and Analysis for Disease Diagnostics

Published on: February 19, 2017

9.2K

Videos de Experimentos Relacionados

Last Updated: Mar 8, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

2.0K
Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
08:23

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

10.4K
Magnetic Levitation Coupled with Portable Imaging and Analysis for Disease Diagnostics
07:42

Magnetic Levitation Coupled with Portable Imaging and Analysis for Disease Diagnostics

Published on: February 19, 2017

9.2K

Área de la Ciencia:

  • Hematología
  • La genética
  • Biología vascular

Sus antecedentes:

  • La enfermedad de células falciformes (SCD) es un trastorno hematológico prevalente y potencialmente mortal que afecta a millones de personas en todo el mundo.
  • Los eritrocitos anormales causan oclusión vascular, lo que lleva a isquemia tisular, inflamación y crisis dolorosas agudas.
  • El daño crónico de los órganos y la mortalidad temprana son el resultado de la anemia hemolítica y la anemia falciforme repetida.

Objetivo del estudio:

  • Revisar las estrategias terapéuticas actuales y emergentes para la anemia falciforme.
  • Para resaltar los avances recientes en el diagnóstico y el manejo de enfermedades.
  • Para abordar las controversias en curso en la fisiopatología y el tratamiento de la SCD.

Principales métodos:

  • Revisión de la literatura sobre los tratamientos actuales y la investigación en curso en la enfermedad de células falciformes.
  • Análisis de los avances recientes en el cribado, el diagnóstico y la gestión.
  • Discusión de los aspectos controvertidos en el CDS.

Principales resultados:

  • Los tratamientos actuales incluyen transfusiones e hidroxicarbamida; el trasplante de células madre ofrece una cura potencial.
  • Las terapias emergentes incluyen terapia génica y edición génica.
  • Los avances recientes abarcan el cribado universal del riesgo de accidente cerebrovascular, el manejo mejorado de la sobrecarga de hierro y los diagnósticos en el punto de atención.

Conclusiones:

  • Se están logrando avances significativos en el manejo de la anemia falciforme, con nuevas terapias en el horizonte.
  • Abordar las controversias en fisiopatología y manejo es crucial para mejorar los resultados de los pacientes.
  • El futuro del tratamiento de la ECS implica una combinación de terapias avanzadas, diagnóstico y atención integral.